fibrosis – APBN New Site

Strategic Partnership to Bring Hope to Patients With Fibrotic and Inflammatory Diseases

February 19, 2020 . Posted in Inside Industry

In January 2020, the partnership between Enleofen Bio and the global pharmaceutical company, Boehringer Ingelheim was announced, to enhance the interleukin-11 programme and advance it to clinical...

New Treatment for Fatty Liver Disease

June 29, 2019 . Posted in Bioboard

A new treatment approach involves blocking a protein - interleukin 11. A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore (NHCS) found that deactivating a...